Icon

EPSOLAY (nda214510)- (5%)

BENZOYL PEROXIDE GALDERMA LABS LP
5%
No Yes
2040-Dec-27 Expired
None 2025-Apr-22
None No
EPZICOM, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
0 0 0
Total Other Developers 1
Drugs with Suitability No
5% ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.